한국어
Home › Companies › Y-Biologics

Y-Biologics

와이바이오로직스 · 338840 · KOSDAQ
Filings, last 12 months
69
Supply contracts
0
Insider reports
20
Share & bond issues
0

At a glance

Y-Biologics filed 69 disclosures in the last 12 months, including 20 insider and 9 5% holder. The most recent key filing was on Oct 20: CEO bought 6,375 sh on the market at an average ₩7,017, Oct 16–20.

Revenue for 2025 was ₩2.9B, down 49.5% on 2024. It made an operating loss of ₩9.3B. Debt was 110% of equity at year end. The latest interim report (2026 H1) shows revenue of ₩1.8B and operating loss of ₩7.7B.

Financial summary

2023
Revenue ₩3.5B
Op. profit -₩10.1B
Debt/equity 29%
2024
Revenue ₩5.8B
Op. profit -₩8.4B
Debt/equity 18%
2025
Revenue ₩2.9B
Op. profit -₩9.3B
Debt/equity 110%
2026 H1
Revenue ₩1.8B
Op. profit -₩7.7B
Debt/equity 192%
RevenueOperating profitOperating lossConsolidated where available · from periodic reports

Key filings

10/20InsiderBuyCEO bought 6,375 sh on the market at an average ₩7,017, Oct 16–20.₩44.7M
10/15InsiderBuyPresident bought 1,000 sh on the market at an average ₩6,713, Oct 15.₩6.7M
10/15InsiderBuyCEO bought 1,040 sh on the market at an average ₩6,779, Oct 15.₩7.1M
10/14InsiderBuyCEO bought 1,425 sh on the market at an average ₩7,084, Oct 14.₩10.1M
10/14InsiderBuyCEO bought 2,500 sh on the market at an average ₩7,017, Oct 14.₩17.5M
10/15% holderReport of 5%+ holding
8/55% holderReport of 5%+ holding
8/5InsiderInsider ownership report
8/3InsiderInsider ownership report
7/235% holderReport of 5%+ holding
7/23InsiderInsider ownership report
7/95% holderReport of 5%+ holding
7/1InsiderInsider ownership report
7/15% holderReport of 5%+ holding
6/23InsiderInsider ownership report
6/17InsiderInsider ownership report
6/10InsiderInsider ownership report
6/4InsiderInsider ownership report
4/16InsiderInsider ownership report
4/165% holderReport of 5%+ holding
3/19InsiderInsider ownership report
3/195% holderReport of 5%+ holding
12/30InsiderInsider ownership report
12/305% holderReport of 5%+ holding
12/30IssuanceAmendedConvertible bond issue
12/18InsiderInsider ownership report
12/18InsiderInsider ownership report
12/18InsiderInsider ownership report
12/18InsiderInsider ownership report
12/185% holderReport of 5%+ holding

Other filings

10/23IR event
10/1Filing
9/22Shareholders' meeting
9/4Filing
9/4Shareholders' meeting
8/14Shareholders' meeting
8/14Filing
8/14Half-year report
8/14Filing
7/3Filing
7/3Filing
7/3Shareholders' meeting
6/12Filing
6/12Shareholders' meeting
5/27Filing
5/27Shareholders' meeting
5/19Shareholders' meeting
5/15Quarterly report
4/23Filing
4/16Filing
4/13Shareholders' meeting
4/13Shareholders' meeting
4/9Filing
4/6Filing
3/31Filing
3/31Shareholders' meeting
3/23Annual report
3/23Audit report
3/17Filing
3/16Shareholders' meeting
3/16Shareholders' meeting
3/12Change in revenue or profit of 30%+
3/12Filing
2/24Filing
12/31Convertible bond issue
12/30Convertible bond issue
12/16Filing
12/11Filing
11/14Quarterly report

Links open the original filing on DART, in Korean.